abstract |
This disclosure provides anti-CXCR5 antibodies and their use in ameliorating, treating or preventing lupus. The present disclosure also provides prophylactic, immunotherapeutic, and diagnostic compositions comprising anti-CXCR5 antibodies, and the use of such anti-CXCR5 antibodies in methods of preventing or treating lupus in mammals, including humans. |